Clinical Trial Update: SGLT2i, Pioglitazone, and Ketone Production in T2D [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial at The University of Texas Health Science Center at San Antonio is recruiting to study the effects of an SGLT2 inhibitor and pioglitazo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)
• SGLT2 inhibitors (SGLT2 inhibitor)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Type 2 Diabetes | Phase 1 | Status: RECRUITING